New hepatitis B vaccine
NZPA-AAP Sydney A new vaccine makes a breakthrough in Australia’s fight against the highly-infectious and potentially fatal Hepatitis B virus. Engerix B is the first genetically engineered vaccine to reach the market in Australia and medical experts expect it to be the forerunner of a new breed of sophisticated vaccines. Professor Yvonne Cossart, the head of Sydney University’s infectious diseases department, said the vaccine eventually
would result in all Australian babies being immunised against Hepatitis B. At about sAust23 ($24.60) a dose, Engerix B was half the price of the existing Hepatitis - B vaccine and easier to supply in large quantities, Professor Cossart told a news conference. Professor Cossart said she expected further price reductions for the vaccine to follow, making it easier to persuade governments to introduce widespread immunisation programmes.
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/CHP19880125.2.78
Bibliographic details
Press, 25 January 1988, Page 8
Word Count
135New hepatitis B vaccine Press, 25 January 1988, Page 8
Using This Item
Stuff Ltd is the copyright owner for the Press. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons BY-NC-SA 3.0 New Zealand licence. This newspaper is not available for commercial use without the consent of Stuff Ltd. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.
Copyright in all Footrot Flats cartoons is owned by Diogenes Designs Ltd. The National Library has been granted permission to digitise these cartoons and make them available online as part of this digitised version of the Press. You can search, browse, and print Footrot Flats cartoons for research and personal study only. Permission must be obtained from Diogenes Designs Ltd for any other use.
Acknowledgements
This newspaper was digitised in partnership with Christchurch City Libraries.
Log in